West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. (WPS)

Market Closed
15 Oct, 08:00 PM
XDUS XDUS
€
339. 80
+4
+1.1912%
€
- Market Cap
49.01 P/E Ratio
0.88% Div Yield
10 Volume
7.62 Eps
€ 335.8
Previous Close
Add Transaction
Day Range
331.6 339.8
Year Range
187.85 339.8
Want to track WPS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

WPS closed yesterday higher at €339.8, an increase of 1.1912% from Wednesday's close, completing a monthly increase of 16.6495% or €48.5. Over the past 12 months, WPS stock gained 46.7185%.
WPS pays dividends to its shareholders, with the most recent payment made on Aug 05, 2026. The next estimated payment will be in In 2 weeks on Nov 05, 2026 for a total of €0.22.
The last earnings report, released on Apr 23, 2026, missed the consensus estimates by -1.68%. On average, the company has fell short of earnings expectations by -0.3967%, based on the last three reports.
West Pharmaceutical Services, Inc. has completed 4 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

WPS Chart

West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?

West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?

West Pharmaceutical Services  WST shares have gained 36.1% year to date, significantly outperforming its industry's advancement of 7.8%. The rally reflects improving demand for high-value pharmaceutical packaging components, stronger-than-expected earnings, and an upward revision to full-year guidance.

Zacks | 1 day ago
West Pharma: Still A Buy, But Expectations Are Rising

West Pharma: Still A Buy, But Expectations Are Rising

West Pharmaceutical Services remains a buy despite a demanding valuation, driven by new growth catalysts and robust financial performance. Double-digit growth from GLP-1s, HVP upgrades, and the multiyear Annex 1 regulatory opportunity underpin WST's bullish outlook. Annex 1 upgrades represent a multiyear, regulatory-driven mix shift, with only ~1B of a 6B component opportunity converted so far.

Seekingalpha | 1 week ago
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

West Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.

Zacks | 4 weeks ago

West Pharmaceutical Services, Inc. (WPS) FAQ

What is the stock price today?

The current price is €339.80.

On which exchange is it traded?

West Pharmaceutical Services, Inc. is listed on XDUS.

What is its stock symbol?

The ticker symbol is WPS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.88%.

What is its market cap?

As of today, no market cap data is available.

Has West Pharmaceutical Services, Inc. ever had a stock split?

West Pharmaceutical Services, Inc. had 4 splits and the recent split was on Sep 27, 2013.

West Pharmaceutical Services, Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Michel Lagarde CEO
XDUS Exchange
US9553061055 ISIN
US Country
10,800 Employees
29 Jul 2026 Last Dividend
27 Sep 2013 Last Split
13 Jan 1978 IPO Date

Overview

West Pharmaceutical Services, Inc. is a leading global provider in the design, manufacturing, and sale of containment and delivery systems for injectable drugs and healthcare products. With a presence across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, the company operates through two primary segments: Proprietary Products and Contract-Manufactured Products. Founded in 1923 and headquartered in Exton, Pennsylvania, West Pharmaceutical Services, Inc. is dedicated to serving biologic, generic, and pharmaceutical drug companies, as well as pharmaceutical, diagnostic, and medical device companies through a comprehensive sales force, distribution network, contract sales agents, and regional distributors.

Products and Services

  • Stoppers and Seals for Injectable Packaging Systems: These are designed for use in vials and other packaging systems to ensure the integrity and sterility of injectable drugs.
  • Syringe and Cartridge Components: This includes custom solutions for injectable drug applications, offering enhanced safety and efficiency in drug delivery through advanced technologies in reconstitution, mixing, and transfer.
  • Films, Coatings, Washing, Vision Inspection, and Sterilization Services: These services aim to improve the quality of packaging components, ensuring that they meet stringent healthcare standards.
  • Drug Containment Solutions: Among their offerings is Crystal Zenith, a high-performance cyclic olefin polymer used in formulating vials, syringes, and cartridges. This product line is geared towards providing superior containment solutions for sensitive biologics and other pharmaceuticals.
  • Self-Injection Devices: These devices are designed to facilitate self-administration of drugs, improving patient compliance and convenience. West also offers a variety of integrated services such as analytical lab services, pre-approval primary packaging support, engineering development, regulatory expertise, and after-sales technical support to complement these offerings.
  • Design, Manufacture, and Automated Assembly of Devices: Within their Contract-Manufactured Products segment, the focus is on creating devices for surgical, diagnostic, ophthalmic, injectable, and various drug delivery systems, as well as consumer products. This entails a close collaboration with pharmaceutical, diagnostic, and medical device companies to develop solutions that meet specific requirements.

Contact Information

Address: 530 Herman O. West Drive
Phone: 610 594 2900